Pure Global
Singapore HSA registration DE0507958

Diasorin LIAISON® Direct Renin

Singapore flagSingapore·CLASS B IVD·DiaSorin Italia S.p.A.·Registered March 30, 2023
Device classification
Device Class
CLASS B IVD
Medical Speciality Area
Immunology
Registration information
Registration Number
DE0507958
Registration Date
March 30, 2023
Retention Due Date
March 29, 2026
Product description
The LIAISON® Direct Renin assay uses chemiluminescence immunoassay (CLIA) technology for the in vitro quantitative determination of renin in human EDTA-plasma specimens. Renin measurement is of help in the diagnosis and treatment of a number of hypertension types in humans. The test has to be performed on the LIAISON® Analyzer family.
Product Owner
Name
DiaSorin Italia S.p.A.
Short Name
DiaSorin Italia S.p.A.
Address
Via Crescentino, snc, 13040 Saluggia (VC) Italy, ITALY
Registrant
Name
SPD SCIENTIFIC PTE LTD
Address
100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Importer
Name
SPD SCIENTIFIC PTE LTD
Address
100H PASIR PANJANG ROAD, OC@PASIR PANJANG, #07-01, SINGAPORE 118524
Model information
Model Name(s)
LIAISON Direct Renin LIAISON Control Direct Renin
Model Identifier(s)
310470 310471
About this record

Access comprehensive regulatory information for Diasorin LIAISON® Direct Renin in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0507958 and owned by DiaSorin Italia S.p.A.. The device was registered on March 30, 2023.

This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.

Free DatabasePowered by Pure Global AIHSA Official DataCLASS B IVD